![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Acer Therapeutics Com USD0.01 | NASDAQ:OPXA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0 | - |
Texas
|
|
001-33004
|
|
76-0333165
|
(State
or other jurisdiction ofincorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
222 Third Street, Suite #2240, Cambridge,
Massachusetts
|
|
02142
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
||
Registrant’s
telephone number, including area code:
(844) 902-6100
|
||
N/A
|
||
(Former
name or former address, if changed since last report)
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Exhibit
No.
|
|
Description
|
|
Press
release issued by Acer Therapeutics Inc. on October 5,
2017.
|
Dated: October 5, 2017 |
ACER THERAPEUTICS
INC.
|
|
|
|
|
|
|
|
By:
|
/s/
Harry S.
Palmin
|
|
|
|
Harry S.
Palmin
|
|
|
|
Chief
Financial Officer
|
|
1 Year Acer Therapeutics Com USD0.01 Chart |
1 Month Acer Therapeutics Com USD0.01 Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions